BioDelivery Sciences

About:

BioDelivery Sciences is a pharmaceutical company that focuses on pain management and addiction medicine.

Website: http://www.bdsi.com

Twitter/X: BioDeliverySI

Top Investors: MidCap Financial, CRG, BioPharma Credit, Federated Kaufmann Fund, Broadfin Capital

Description:

BioDelivery Sciences is a pharmaceutical company that focuses on pain management and addiction medicine. They are utilizing their novel and proprietary BioErodible MucoAdhesive (BEMA) drug delivery technology to develop and commercialize, either on their own or in partnership with third parties, new applications of proven therapies aimed at addressing important unmet medical needs.

Total Funding Amount:

$251M

Estimated Revenue Range:

$50M to $100M

Headquarters Location:

Raleigh, North Carolina, United States

Founded Date:

1997-01-01

Founders:

Number of Employees:

101-250

Last Funding Date:

2019-05-28

IPO Status:

Public

Industries:

© 2025 bioDAO.ai